In One Chart Published: Aug. 8, 2020 at 5:59 a.m. ET America’s COVID-19 death toll in the U.S. could reach nearly 300,000 by Dec. 1, according to a new projection ‘As infections drop, people let their guard down and stop taking these measures to protect themselves,’ said Christopher Murray, director of the Institute for Health…
Published June 28, 2020Updated June 29, 2020, 12:57 a.m. ETHOUSTON — Melissa Estrada had tried to be so careful about the coronavirus. For months she kept her three children at home, and she always wore a mask at the grocery store. She and her daughter even stitched face coverings for relatives and friends.But over the…
reported case spikes among young adults in its two largest college towns, Ames and Iowa City, after the governor allowed bars to reopen. And on campuses across the country, attempts to bring back football teams for preseason practice have resulted in outbreaks.More than 130 coronavirus cases have been linked to athletic departments at 28 Division…
WASHINGTON (AP) — A husband coughing up blood. A sister close to death. Another friend felled by the coronavirus. The beat against Congress has always been that its members are out of touch with average Americans. But that’s not true when it comes to the brutality of COVID-19 and its march across boundaries of wealth,…
I was officially diagnosed with Lupus in May of 2021. I say officially because my symptoms started long before that, I just didn't know it. Lupus is a chronic autoimmune disease that can cause inflammation and pain in different parts of the body. Your immune system is meant to help your body fight infection. But
Pros Has a sturdy, 11-gauge steel build Supports up to 500 pounds Costs less than $100 Cons Only comes with a straight bar Sticks out two feet from the wall We like the Titan Fitness Adjustable Depth Pull-Up Bar because it’s sturdy, bare-bones, and relatively affordable. The mounting is a touch more complicated than doorway-mounted
Duodenal mucosal resurfacing (DMR) — an investigational endoscopic procedure — helped patients maintain weight loss, and in some cases, even lose additional weight, 3 months after discontinuing GLP-1 receptor agonist therapy, initial results of the open-label, multistage REMAIN-1 trial showed. In addition, “the procedure was well tolerated, with only minor, transient TEAEs [treatment-emergent adverse events]